| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |